Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 189.65M | 186.86M | 189.06M | 179.99M | 172.84M | 165.78M |
Gross Profit | 165.60M | 163.72M | 168.87M | 162.04M | 155.13M | 68.14M |
EBITDA | 140.42M | 139.80M | 144.97M | 139.96M | 133.74M | 117.81M |
Net Income | 39.55M | 42.66M | 24.04M | -7.98M | 402.66M | 36.78M |
Balance Sheet | ||||||
Total Assets | 2.02B | 2.01B | 2.10B | 2.22B | 2.18B | 3.21B |
Cash, Cash Equivalents and Short-Term Investments | 24.83M | 39.84M | 202.02M | 12.92M | 32.36M | 53.17M |
Total Debt | 626.34M | 563.41M | 564.31M | 622.14M | 27.41M | 1.12B |
Total Liabilities | 661.37M | 603.89M | 605.14M | 664.71M | 576.42M | 1.55B |
Stockholders Equity | 1.36B | 1.40B | 1.49B | 1.56B | 1.60B | 1.65B |
Cash Flow | ||||||
Free Cash Flow | 117.45M | 129.86M | 125.75M | 113.23M | 111.66M | 80.90M |
Operating Cash Flow | 120.69M | 132.85M | 128.92M | 121.67M | 136.94M | 109.70M |
Investing Cash Flow | -82.43M | -149.69M | 197.31M | -142.81M | 1.23B | -41.42M |
Financing Cash Flow | -100.56M | -145.50M | -137.13M | 1.34M | -1.40B | -83.74M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $1.42B | 36.42 | 2.71% | 6.19% | 0.43% | 58.57% | |
75 Outperform | 1.65B | 19.63 | 8.69% | 6.37% | 8.18% | -16.83% | |
64 Neutral | 547.87M | 111.89 | 1.24% | 10.36% | 0.90% | 0.00% | |
59 Neutral | 1.11B | -3.83 | -15.46% | 0.87% | 4.29% | 18.89% | |
55 Neutral | 3.01B | -2.10 | -49.87% | 6.39% | 27.66% | 18.03% | |
52 Neutral | 426.07M | -38.80 | -1.69% | 12.48% | 2.96% | -877.53% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
On September 8, 2025, Sila Realty Trust, Inc. released an investor presentation for use at various conferences and meetings. The presentation highlights the company’s strong financial metrics and strategic focus on the healthcare sector, emphasizing long-term lease terms and a disciplined capital structure. This move is part of Sila’s strategy to maintain its position in the healthcare real estate market, leveraging demographic trends and economic factors to support sustainable growth.
On August 12, 2025, Sila Realty Trust, Inc. entered into an Equity Offering Sales Agreement with several financial institutions to offer and sell up to $250 million in common stock. This agreement allows the company to sell shares through market offerings or forward sale agreements, with proceeds intended for general corporate purposes such as repaying credit facilities or funding acquisitions, potentially impacting the company’s financial flexibility and growth strategy.
Sila Realty Trust, Inc. announced its second-quarter 2025 financial results, reporting a net income of $8.6 million and cash net operating income of $41.9 million. The company declared a quarterly cash dividend of $0.40 per share and authorized a $75 million share repurchase program over three years. Sila acquired an inpatient rehabilitation facility in Delaware and two medical outpatient buildings in Texas, enhancing its healthcare property portfolio. The company remains optimistic about its strategic focus on necessity-based healthcare solutions despite economic challenges.